As of May 27
| +0.40 / +0.60%|
The 1 analysts offering 12-month price forecasts for Cantel Medical Corp have a median target of 54.00, with a high estimate of 54.00 and a low estimate of 54.00. The median estimate represents a -19.17% decrease from the last price of 66.81.
The current consensus among 1 polled investment analysts is to Hold stock in Cantel Medical Corp. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.